Antiseptic Rinse of Bowel Segment During Bladder Removal Surgery
Tests a chlorhexidine antiseptic rinse in adults having bladder cancer surgery with urinary diversion.
Key facts
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
- Status
- Recruiting
- People taking part
- 23 people, planned
- Started
- 1 Aug 2024
- Planned end
- 1 Jul 2026
- Type of study
- Interventional
- Treatments tested
- Irrisept® Antimicrobial Wound Lavage
- Record updated
- 15 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with bladder cancer who will have the bladder removed (radical cystectomy) with an ileal conduit or neobladder. The bowel segment is rinsed with Irrisept (chlorhexidine).
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Confirmed bladder cancer, planned for radical cystectomy with urinary diversion; ECOG performance status 0-2
- Biomarker or test result
- Serum creatinine ≤ 1.5 mg/dL (133 µmol/L)
Main reasons for not taking part
- Planned or past urinary diversion other than ileal conduit or neobladder
- Pregnancy or breastfeeding
- Known allergy to Irrisept or chlorhexidine
- Uncontrolled other illness, such as active infection, symptomatic heart failure, unstable angina or heart rhythm problems
- Psychiatric illness or social situation that the investigator thinks would limit following the study
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Provision of signed and dated informed consent form
- Stated availability for the duration of the study, and willingness to comply with all study procedures, including willingness to adhere to twice daily irrigation of neobladder or ileal conduit
- Male or female, ≥ 18 years of age
- Confirmed diagnosis of bladder cancer
- Candidate for radical cystectomy with urinary diversion
- ECOG performance status of 0-2
- Serum creatinine ≤ 1.5 mg/dL
Who cannot take part
- Known allergic reactions to components of the Irrisept irrigating system, chlorhexidine
- Patient must not have any uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that, in the opinion of the investigator, would limit compliance with study requirements
- Has undergone or planned to undergo urinary diversion other than ileal conduit or neobladder
- Pregnancy or lactation
Where in United States
- Mount Sinai HospitalNew York, United StatesContact: John Sfakianos, MDTaking people
About the trial
What the trial wants to find out
This is a single arm, interventional pilot study of using chlorhexidine irrigation intra-operatively and post-operatively among patients undergoing radical cystectomy with urinary diversion. The intervention comprises of using irrigation of ileal conduit or ileal neobladder intra-operatively and then for irrigation of either post-surgery with Irrisept ®. The sterilization of urine will be assessed at 10 days after cystectomy. Incidence of symptomatic urinary tract infections within the 30-day post-operative period will be estimated.
The group in the trial
- Patients undergoing radical cystectomy with urinary diversionTreatment being tested
Patients undergoing radical cystectomy and ileal conduit or ileal neobladder will receive Irrisept ® Antimicrobial Wound Lavage as intervention
Treatment: Irrisept® Antimicrobial Wound Lavage
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion After Chlorhexidine Irrigation in Patients Undergoing Radical Cystectomy
- Plain-language title
- Antiseptic Rinse of Bowel Segment During Bladder Removal SurgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 December 2025